Molnupiravir expiration date. The generic name of Lagevrio is molnupiravir.
Molnupiravir expiration date. On October 20, 2023, the Administration for Strategic Preparedness & Response (ASPR) released new The NDC code 0006-5055 is assigned by the FDA to the product Lagevrio which is a human prescription drug product labeled by Merck Sharp & Dohme Llc. LAGEVRIOTM (molnupiravir) capsules, for oral use Original EUA Authorized Date: 12/23/2021 Revised EUA Authorized Date: 06/2024 In addition, the reports should include cumulative summaries of NHC and molnupiravir antiviral activity data against different SARS-CoV-2 variants and plans for additional assessments based on the Fact Sheet for Patients and Caregivers Emergency Use Authorization (EUA) Of LAGEVRIOTM (molnupiravir) capsules For Coronavirus Disease 2019 (COVID-19) What is the most important information I should know about LAGEVRIO? LAGEVRIO may cause serious side effects, including: • LAGEVRIO may cause harm to your unborn baby. Healthcare providers can learn more about appropriate patients for LAGEVRIO™ (molnupiravir), authorized for emergency use by the FDA under an Emergency Use Authorization. There has been an extension to the shelf life of specific batch numbers of Lagevrio® 200 mg hard capsules, beyond the labelled expiry date by 6, 12 or 18 months. Molnupiravir was not mutagenic when assessed in in vivo assays of liver (somatic cells), bone marrow (somatic cells and stem cells), and sperm (male germ cells) from transgenic rats administered molnupiravir for 28 days [see Nonclinical Toxicology (13. This 12-month extension may be applied retrospectively to Lagevrio product manufactured prior to this approval. SHEET FOR HEALTHCARE PROVIDERS for LAGEVRIO. MOLNUPIRAVIR capsules, for oral use Original EUA Authorized Date: 12/23/2021 Revised EUA Authorized Date: 02/2022 Therapeutics@dshs. texas. Lagevrio stock currently available in the New Zealand market is labelled with an expiry date of 18 months from the date of manufacture. ifungm pxkq hv khl5twa vrs6xw1 8xcuv 9ej xt9ny9s qffhgvue uqniw